Adherence to glycemic monitoring in diabetes

Journal of Diabetes Science and Technology

Volumn 9, Issue 3, 2015, Pages 668-675

  Patton, Susana R ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Center for Children's Healthy Lifestyles and Nutrition   (United States)

Author keywords

Adherence; Continuous glucose monitoring; Intervention; Measurement; Self monitoring of blood glucose

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; COGNITIVE THERAPY; CONTINUOUS GLUCOSE MONITORING; DIABETES EDUCATION; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PROBLEM SOLVING; REVIEW; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; STANDARDS;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; HUMANS; PATIENT COMPLIANCE;

EID: 84953714807     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814567709     Document Type: Review

References (45)

1. Chiang JL, Kirkman MS, Laffel LM, et al. Type 1 diabetes sourcebook, type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034-2054.
2. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
3. Rewers MJ, Pillay K, de Beaufort C, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(suppl 20):102-114.
4. Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22(10):1379-1385.
5. Harris MI, National Health and Nutrition Examination Survey. Frequency of blood glucose monitoring in relation to glyce-mic control in patients with type 2 diabetes. Diabetes Care. 2001;24(6):979-982.
6. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-125.
7. Simmons JH, Chen V, Miller KM, et al. Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. Diabetes Care. 2013;36(11):3573-3577.
8. Driscoll KA, Johnson SB, Hogan J, et al. Insulin bolusing software: the potential to optimize health outcomes in type 1 diabetes mellitus. J Diabetes Sci Technol. 2013;7(3):646-652.
9. O'Connell MA, Donath S, Cameron FJ. Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes. 2011;12(6):556-559.
10. Wong JC, Foster NC, Maahs DM, et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014;37(10):2702-2709.
11. Schmidt S, Duun-Henriksen AK, Norgaard K. Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes. J Diabetes Sci Technol. 2012;6(4):986-987.
12. Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study. Patient Prefer Adherence. 2014;8:237-246.
13. Hortensius J, Kars MC, Wierenga WS, et al. Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Public Health. 2012;12:167.
14. Cafazzo JA, Casselman M, Hamming N, et al. Design of an mHealth app for the self-management of adolescent type 1 diabetes: a pilot study. J Med Internet Res. 2012;14(3):e70.
15. Raiff BR, Dallery J. Internet-based contingency management to improve adherence with blood glucose testing recommendations for teens with type 1 diabetes. J Appl Behav Anal. 2010;43(3):487-491.
16. Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014;37(3):625-633.
17. Stanger C, Ryan SR, Delhey LM, et al. A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study. J Pediatr Psychol. 2013;38(6):629-637.
18. Tan MY, Magarey JM, Chee SS, et al. A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes. Health Educ Res. 2011;26(5):896-907.
19. Suh S, Jean C, Koo M, et al. A randomized controlled trial of an internet-based mentoring program for type 1 diabetes patients with inadequate glycemic control. Diabetes Metab J. 2014;38(2):134-142.
20. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36(7):2009-2014.
21. Ziegler R, Heidtmann B, Hilgard D, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11-17.
22. Bosi E, Scavini M, Ceriello A, et al. Intensive structured self-monitoring of blood glucose and glycemic control in nonin-sulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care. 2013;36(10):2887-2894.
23. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510-1517.
24. Campbell MS, Schatz DA, Chen V, et al. A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes. 2014;15(2):110-117.
25. Borus JS, Blood E, Volkening LK, et al. Momentary assessment of social context and glucose monitoring adherence in adolescents with type 1 diabetes. J Adolesc Health. 2013;52(5):578-583.
26. Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523-1537.
27. White CA. Cognitive behavioral principles in managing chronic disease. West J Med. 2001;175(5):338-342.
28. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychoth. 1995;23:325-334.
29. Polonsky WH, Hessler D. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther. 2013;15(4):295-301.
30. McQueen RB, Ellis SL, Maahs DM, et al. Frequency of continuous glucose monitoring use and change in hemoglobin A1C for adults with type 1 diabetes in a clinical practice setting. Endocr Pract. 2014;20(10):1007-1015.
31. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Trial. Diabetes Care. 2010;33(1): 17-22.
32. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Hirsch IB, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378-1383.
33. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-1476.
34. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes. 2006;114(2):63-67.
35. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
36. Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care. 2009;32(12):2245-2250.
37. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, et al. Factors predictive of use and benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32: 1947-1953.
38. Diabetes Research in Children Network Study Group, Buckingham B, Beck RW, et al. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr. 2007;151(4): 388-393.
39. Mauras N, Beck R, Xing D, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012;35(2)
40. Tsalikian E, Fox L, Weinzimer S, et al. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes. 2012;13(4):301-307.
41. Rachmiel M, Landau Z, Boaz M, et al. The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience [published online ahead of print September 16, 2014]. Acta Diabetol.
42. Ritholz MD, Atakov-Castillo A, Beste M, et al. Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med. 2010;27(9):1060-1065.
43. Olivier P, Lawson ML, Huot C, et al. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy. J Diabetes Sci Technol. 2014;8(3):523-528.
44. Wysocki T, Iannotti R, Weissberg-Benchell J, et al. Diabetes problem solving by youths with type 1 diabetes and their care-givers: measurement, validation, and longitudinal associations with glycemic control. J Pediatr Psychol. 2008;33(8):875-884.
45. Petry NM, Cengiz E, Wagner JA, et al. Incentivizing behaviour change to improve diabetes care. Diabetes Obes Metab. 2013;15(12):1071-1076.